IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $36 | -78.2% | 1,019 | -76.7% | 0.00% | – |
| Q4 2022 | $165 | -100.0% | 4,370 | -87.4% | 0.00% | -100.0% |
| Q2 2022 | $1,281,000 | +748.3% | 34,626 | +748.9% | 0.00% | – |
| Q1 2022 | $151,000 | -83.2% | 4,079 | -81.9% | 0.00% | -100.0% |
| Q3 2021 | $901,000 | +5.9% | 22,512 | +5.4% | 0.00% | 0.0% |
| Q2 2021 | $851,000 | +2402.9% | 21,354 | +2655.4% | 0.00% | – |
| Q1 2021 | $34,000 | -20.9% | 775 | 0.0% | 0.00% | – |
| Q4 2020 | $43,000 | -93.2% | 775 | -92.8% | 0.00% | -100.0% |
| Q2 2020 | $630,000 | +121.8% | 10,697 | +77.9% | 0.00% | 0.0% |
| Q1 2020 | $284,000 | -19.8% | 6,012 | +2.4% | 0.00% | 0.0% |
| Q4 2019 | $354,000 | -63.6% | 5,870 | -63.8% | 0.00% | -66.7% |
| Q3 2019 | $972,000 | -34.7% | 16,235 | -30.0% | 0.00% | -25.0% |
| Q2 2019 | $1,489,000 | -37.5% | 23,183 | -21.1% | 0.00% | -42.9% |
| Q1 2019 | $2,383,000 | +31.6% | 29,368 | -12.4% | 0.01% | +40.0% |
| Q4 2018 | $1,811,000 | +123.9% | 33,512 | +113.6% | 0.01% | +66.7% |
| Q3 2018 | $809,000 | +288.9% | 15,689 | +212.8% | 0.00% | +200.0% |
| Q2 2018 | $208,000 | -72.4% | 5,015 | -70.7% | 0.00% | -97.0% |
| Q1 2018 | $753,000 | -27.7% | 17,087 | -17.6% | 0.03% | -26.7% |
| Q4 2017 | $1,042,000 | +683.5% | 20,730 | +687.9% | 0.04% | +650.0% |
| Q2 2017 | $133,000 | -91.4% | 2,631 | -93.2% | 0.01% | -91.0% |
| Q1 2017 | $1,550,000 | -10.6% | 38,575 | -18.5% | 0.07% | -42.7% |
| Q3 2016 | $1,733,000 | +1003.8% | 47,310 | +598.2% | 0.12% | +1070.0% |
| Q2 2016 | $157,000 | -61.1% | 6,776 | -32.2% | 0.01% | -68.8% |
| Q1 2016 | $404,000 | +104.0% | 9,988 | +211.7% | 0.03% | +100.0% |
| Q4 2015 | $198,000 | – | 3,204 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |